-+ 0.00%
-+ 0.00%
-+ 0.00%

Esprinet Presents 31% Rise in Nine-Month Adjusted EBITDA to EUR 49 Million

PUBT·11/19/2026 13:59:31
Listen to the news
Esprinet Presents 31% Rise in Nine-Month Adjusted EBITDA to EUR 49 Million
  • Esprinet reported nine-month 2026 adjusted EBITDA of €49 million, up 31%, in an investor presentation in Madrid.
  • Gross sales rose 11% to €3.5 billion, outpacing the market.
  • Adjusted EBITDA margin increased to 1.53% from 1.29%, as operating costs grew more slowly than revenue.
  • Net financial debt reached €417.8 million at September 30, versus €287.2 million a year earlier, reflecting working capital pressure.
  • Higher inventories supported supply continuity; the cash conversion cycle increased two days from the previous quarter to 27 days.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Esprinet S.p.A. published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.